Bruker Corp Files 8-K on Financials
Ticker: BRKRP · Form: 8-K · Filed: Aug 6, 2024 · CIK: 1109354
| Field | Detail |
|---|---|
| Company | Bruker Corp (BRKRP) |
| Form Type | 8-K |
| Filed Date | Aug 6, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: BRKR
TL;DR
Bruker Corp dropped an 8-K detailing their latest financial results. Check it out.
AI Summary
Bruker Corporation filed an 8-K on August 6, 2024, reporting on its results of operations and financial condition, as well as providing financial statements and exhibits. The filing details the company's performance and financial status as of August 6, 2024.
Why It Matters
This filing provides investors with crucial updates on Bruker Corporation's financial health and operational results, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial disclosure filing, not indicating any immediate or unusual risks.
Key Players & Entities
- Bruker Corporation (company) — Registrant
- 000-30833 (company) — SEC File Number
- 04-3110160 (company) — I.R.S. Employer Identification No.
- 40 Manning Road Billerica, MA 01821 (company) — Principal executive offices address
- August 6, 2024 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this Form 8-K filing for Bruker Corporation?
The primary purpose is to report on Bruker Corporation's Results of Operations and Financial Condition, and to provide Financial Statements and Exhibits.
On what date was this Form 8-K report filed?
The report was filed on August 6, 2024.
What is Bruker Corporation's principal executive office address?
Bruker Corporation's principal executive office is located at 40 Manning Road, Billerica, MA 01821.
What is Bruker Corporation's SEC File Number?
Bruker Corporation's SEC File Number is 000-30833.
What is the fiscal year end for Bruker Corporation?
Bruker Corporation's fiscal year ends on December 31.
Filing Stats: 562 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-08-06 07:00:08
Key Financial Figures
- $0.01 — nge on Which Registered Common Stock, $0.01 par value per share BRKR The Nasdaq
Filing Documents
- brkr-20240806.htm (8-K) — 48KB
- brkr-ex99_1.htm (EX-99.1) — 896KB
- img53376846_0.jpg (GRAPHIC) — 12KB
- 0000950170-24-091188.txt ( ) — 1113KB
- brkr-20240806.xsd (EX-101.SCH) — 29KB
- brkr-20240806_htm.xml (XML) — 4KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On August 6, 2024, Bruker Corporation issued a press release announcing financial results as of and for the three and six months ended June 30, 2024. A copy of the press release is attached hereto as Exhibit 99.1. The information furnished in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing of the company under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. Cautionary Note Regarding Forward-Looking Statements Except for historical information contained in the press release attached hereto as Exhibit 99.1, the press release contains forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ materially from those indicated by these statements. Please refer to the cautionary note contained in the press release under the heading "Forward-Looking Statements" for additional information regarding these forward-looking statements. Section 9 – Financial Statements and Exhibits
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Number Description 99.1 Press release dated August 6, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BRUKER CORPORATION (Registrant) Date: August 6, 2024 By: /s/ GERALD N. HERMAN Gerald N. Herman Executive Vice President and Chief Financial Officer